NSCI vs. OBI, OPTI, SNG, SBTX, OBD, ONC, BVX, IMM, DEST, and HEMO
Should you be buying NetScientific stock or one of its competitors? The main competitors of NetScientific include Ondine Biomedical (OBI), OptiBiotix Health (OPTI), Synairgen (SNG), SkinBioTherapeutics (SBTX), Oxford BioDynamics (OBD), Oncimmune (ONC), BiVictriX Therapeutics (BVX), ImmuPharma (IMM), Destiny Pharma (DEST), and Hemogenyx Pharmaceuticals (HEMO). These companies are all part of the "biotechnology" industry.
NetScientific (LON:NSCI) and Ondine Biomedical (LON:OBI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, community ranking, analyst recommendations, institutional ownership, media sentiment, profitability and earnings.
Ondine Biomedical has a net margin of 0.00% compared to NetScientific's net margin of -221.55%. NetScientific's return on equity of -21.43% beat Ondine Biomedical's return on equity.
NetScientific received 70 more outperform votes than Ondine Biomedical when rated by MarketBeat users. However, 100.00% of users gave Ondine Biomedical an outperform vote while only 69.61% of users gave NetScientific an outperform vote.
NetScientific has a beta of 1.45, suggesting that its share price is 45% more volatile than the S&P 500. Comparatively, Ondine Biomedical has a beta of -0.14, suggesting that its share price is 114% less volatile than the S&P 500.
NetScientific has higher revenue and earnings than Ondine Biomedical. NetScientific is trading at a lower price-to-earnings ratio than Ondine Biomedical, indicating that it is currently the more affordable of the two stocks.
In the previous week, Ondine Biomedical had 3 more articles in the media than NetScientific. MarketBeat recorded 3 mentions for Ondine Biomedical and 0 mentions for NetScientific. NetScientific's average media sentiment score of 0.00 beat Ondine Biomedical's score of -0.21 indicating that NetScientific is being referred to more favorably in the media.
4.3% of NetScientific shares are held by institutional investors. Comparatively, 8.9% of Ondine Biomedical shares are held by institutional investors. 40.1% of NetScientific shares are held by insiders. Comparatively, 61.5% of Ondine Biomedical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Summary
Ondine Biomedical beats NetScientific on 8 of the 15 factors compared between the two stocks.
Get NetScientific News Delivered to You Automatically
Sign up to receive the latest news and ratings for NSCI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NSCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
NetScientific Competitors List
Related Companies and Tools
